Great experience! Truthfully I'd never heard of banking stem cells for dogs before Gallant, but after reading up on it I realized what an untapped resource it was. I hope we never have to use them, but it give me peace of mind to know that they're there, just in case.
Claim your business profile now and gain access to all features and respond to customer reviews.
Gallant is a clinical-stage animal health biotechnology company setting a new standard in animal health by harnessing the power of stem cell therapy to treat the root cause of diseases in dogs and cats. Our pipeline of off-the-shelf mesenchymal stem cell (MSC) therapies has the potential to treat a broad range of diseases, including canine and feline osteoarthritis (OA), feline chronic kidney disease (CKD), and others. The first product based on our uterine-derived platform for feline chronic gingivostomatitis (FCGS), is on track for conditional approval by the FDA in 2025. United by a love of and commitment to animals, Gallant’s team includes industry pioneers in veterinary regenerative medicine with deep experience in cell therapy product development, manufacturing, and commercialization.See more
